vaccinex Pages on BioPortfolio:

BioPortfolio - vaccinex
BioPortfolio - Vaccinex Incorporated Vaccinex Incorporated - Entry on Bioportfolio's ... View the current Vaccinex Incorporated Page on BioPortfolio.
com . ...
http://www.bioportfolio.com/search/vaccinex.html...

BioPortfolio - Director in Vaccinex
Director in Vaccinex - BioPortfolio. ... Vaccinex Incorporated - Entry on Bioportfolio's Biocorporate Database. ... Recent Search Terms used to find this
...
http://www.bioportfolio.com/search/_Director_in_Vaccinex.htm...

BioPortfolio - vaccinex c35
vaccinex c35 - BioPortfolio. ... Bioportfolio - Vaccinex Incorporated C35 ( C17orf37) is a novel tumor ... a cDNA clone corresponding to a novel gene C35 .
...
http://www.bioportfolio.com/search/vaccinex_c35.html...

BioPortfolio - vaccinex rochester ny
vaccinex rochester ny - BioPortfolio. ... Recent Search Terms used to find this page: vaccinex c17orf37 | . ...
http://www.bioportfolio.com/search/vaccinex_rochester_ny.htm...

BioPortfolio - Vaccinex Incorporated
Vaccinex Incorporated - BioPortfolio. ... Vaccinex Incorporated - Entry on Bioportfolio's Biocorporate Database. ...
http://www.bioportfolio.com/search/Vaccinex_Incorporated.htm...

BioPortfolio - Vaccinex, Inc
Vaccinex, Inc - BioPortfolio. ... About Vaccinex Vaccinex, Inc. is a biotechnology company engaged in the discovery and development of human
monoclonal ...
http://www.bioportfolio.com/search/Vaccinex,_Inc.html...

BioPortfolio - Vaccinex Inc iNKT
Vaccinex Inc iNKT - BioPortfolio. ... Vaccinex Inc iNKT Pages on BioPortfolio: . .. Targeting iNKT cells to the tumor site thus may activate a combined . ...
http://www.bioportfolio.com/search/Vaccinex_Inc_iNKT.html...

Results from other life science and pharmaceutical sites:

URMC and Vaccinex Announce Patent for Technology to Develop ...
The University of Rochester Medical Center and Vaccinex, Inc. announced today the award of a key U.S. patent for a technology platform that can assist ...
http://www.urmc.rochester.edu/pr/News/story.cfm?id=508...

Alliance Vaccinex
Lonza Biologics and Vaccinex Announce Strategic Alliance ... Lonza will provide Vaccinex, its clients and co-development partners with access to its ...
http://www.lonza.com/group/en/company/news/archive/2003/lonz...

BioSpace - Vaccinex, Inc. News, Search Jobs, Events
Vaccinex, Inc. Announces Award of Key Patent in Europe for its Antibody Discovery ... Vaccinex, Inc. Announces Antibody Development and
Commercialization ...
http://www.biospace.com/company_profile.aspx?CompanyId=40310...

Vaccinex Antibody Licensed to GlaxoSmithKline
Vaccinex will share 50% of fees, payments and royalties. The antibody was discovered by Vaccinex utilizing its ActivMAb(R) antibody discovery technology
and ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=...

Vaccinex, Inc. Announces Award of Key Patent in Europe for its ...
30 /PRNewswire/ -- Vaccinex, Inc. announced today the award of a key European patent (European Patent No. 1340088) for its antibody discovery technology ...
http://www.biospace.com/news_story.aspx?NewsEntityId=79038...

BioWorld Today
28 Feb 2007 ... The potential multiple-sclerosis application of Vaccinex Inc.'s preclinical antibody VX15 drew interest from Teva Pharmaceuticals Inc., ...
http://www.bioworld.com/servlet/com.accumedia.web.Dispatcher...

{1} And Biocon To Co-Develop Antibody Pr - News, Search Jobs ...
Vaccinex, Inc. And Biocon To Co-Develop Antibody Products ... As part of the collaboration, Biocon will also make an equity investment in Vaccinex. ...
http://www.biospace.com/news_story.aspx?NewsEntityId=1818582...

Business Alliances - Research Alliances - James P Wilmot Cancer ...
Vaccinex’s proprietary technology offers diverse applications including antigen ... Vaccinex plans to initiate clinical trials in mid-2003 for a promising ...
http://www.urmc.rochester.edu/cancer-center/researchers/rese...

News: First Fully Human Anti-IL6 Antibody Under Development ...
10 Oct 2006 ... Vaccinex granted OPi exclusive worldwide rights to its fully human anti- interleukin-6 (IL-6) antibody, OPR-003, and to several alternate ...
http://www.genengnews.com/news/bnitem.aspx?name=6779735...

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.